Neurogenetics and DNA laboratory

Slides:



Advertisements
Similar presentations
Mapping analysis software Dr Ian Carr PhD. MCSD. Leeds Institute of Molecular Medicine St Jamess University Hospital.
Advertisements

A mild form of Alport syndrome: Hereditary nephropathy in the absence of extra-renal features Yoon H-S, Wilson JC & Eccles MR Pathology, University of.
Note that the genetic map is different for men and women Recombination frequency is higher in meiosis in women.
Genetic Approaches to Rare Diseases: What has worked and what may work for AHC Erin L. Heinzen, Pharm.D, Ph.D Center for Human Genome Variation Duke University.
All Wales Molecular Genetics Laboratory Duplications of the MECP2 gene region and severe mental retardation in males All Wales Molecular Genetics Laboratory.
Tay-Sachs Disease Salman Hossain Kevin Kong. History of tay-Sachs Disease The disease Tay-Sachs is named after ophthalmologist, someone who studies the.
Alport Syndrome: Dealing with Hearing Loss and Advances in Technology
As this disease is most commonly prevalent in the elderly, some members of the class may have relatives with this disease so please be a respectful and.
Tay-sachs Disease Yi Cheng Lisa Nguyen.
Pelizaeus-Merzbacher Disease
POSITIONAL CLONING TWO EXAMPLES. Inheritance pattern - dominant autosomal Entirely penetrant and fatal Frequency - about 1/10,000 live births Late onset.
Retinoblastoma by Michele Chasteen What is Retinoblastoma? n n Tumor of the eye that can occur at a high frequency in children and sporadically at an.
What is Li-Fraumeni syndrome?
HSAN1: Hereditary Sensory and Autonomic Neuropathy Type Dennis Kunkel Microscopy, Inc.
Clinical features of Demyelinating Charcot-Marie-Tooth disease Davide Pareyson “C.Besta” National Neurological Institute Milan, Italy Prague May 25, 2004.
Approach to Inherited Neuropathies
By Robert Johnson SPINAL MUSCULAR ATROPHY. SYMPTOMS INFANT Can have a breathing difficulty Difficulty feeding, food may go down windpipe instead of stomach.
DNA marker analysis Mrs. Stewart Medical Interventions Central Magnet School.
Hearing Loss in Alport Syndrome Dr Sudhira Ratnayake Consultant in Audiovestibular Medicine Gem Centre Royal Wolverhampton NHS Trust 7/2/20151Alport Information.
An Update in Genetics of Epilepsy
Aging, Memory and Alzheimer’s Disease Kinga Szigeti, MD, PhD.
List at least 3 genetic conditions you know of. Why do you think they are genetic conditions?
Spinal Muscular Atrophy SMN1 Billy Baader - Genetics 677 Medline Plus (2009) Spinal Muscular Atrophy retrieved Feb 3, 2009 from:
Mendelian Genetics Chapter 11 Part 2 pp ,
Charcot-Marie-Tooth (CMT) High School Presentation Elizabeth Ouellette
POSITIONAL CLONING TWO EXAMPLES. Inheritance pattern - dominant autosomal Entirely penetrant and fatal Frequency - about 1/10,000 live births Late onset.
Standardization of Pedigree Collection. Genetics of Alzheimer’s Disease Alzheimer’s Disease Gene 1 Gene 2 Environmental Factor 1 Environmental Factor.
C-M-T Project in the Czech Republic
Amyotrophic lateral sclerosis (ALS). What is amyotrophic lateral sclerosis? It is a progressive neurological disease that affects the control of muscle.
Rett Syndrome By Thu Le. What is Rett Syndrome? Progressive neurodevelopment disorder Common cause of profound mental impairment in girls Babies with.
MPZ mutations associated with deafness and abnormal pupillar reaction in Czech CMT2 patients, but also in HMSN III patients. P. Seeman 1, K. Huehne 2,
(DMD) Duchenne Muscular Dystrophy. History of DMD It was first described by a french neurologist named Guillaume Benjamin Amand Duchenne in Previous.
Hemophilia Research Center for Genetic Engineering and Biotechnology “Georgi D. Efremov”, MASA What is: Hemophilia is an X-linked congenital bleeding disorder.
Kearns-Sayre Syndrome Charles Shepherd Bio 313 Charles Shepherd Bio 313.
A Diagnostic Testing Service for Hypophosphatemic Rickets
© 2006 W.W. Norton & Company, Inc. DISCOVER BIOLOGY 3/e 1 Chromosomes and Human Genetics Mendel was unaware of chromosomes  The physical structure of.
Doug Brutlag 2011 Genomics & Medicine Doug Brutlag Professor Emeritus of Biochemistry &
Charcot – Marie Tooth Disease
Haythum O Tayeb R3, Neurology.  Brief review of the genetics and molecular biology of CMT & HNPP with clinical correlation.
1 Dr Pupak Derakhshandeh, PhD Ass Prof of Medical Science of Tehran University SMA SPINAL MUSCULAR ATROPHY.
In The Name of GOD Genetic Polymorphism M.Dianatpour MLD,PHD.
Charcot-Marie- Tooth Disease Jessica Tzeng. History  Named after Jean-Martin Charcot, Pierre Marie (Charcot’s pupil), and Howard Henry Tooth  Not a.
Electrophysiology & Leukodystrophies Shahriar Nafissi Department of Neurology Tehran University of Medical Sciences.
Hypotonia, neuropathies and myopathies
Changes in Chromosome Structure. Change in Chromosomes Often if the chromosome numbers or structures are changed a lot, there are lethal consequences.
CDKL5 gene related epileptic encephalopathy in Estonia: a case presentation Klari Noormets 1,2, Katrin Õunap 2,3, Ulvi Vaher 1, Tiina Talvik 1,2, Inga.
Mendelian Genetics Extended (5.2)
Genetics and its relation to neuromuscular diseases
HSAN1: Hereditary Sensory and Autonomic Neuropathy Type 1
Canavan Disease The causes of, detection of, symptoms of, and treatment of Canavan disease.
Copyright © 2006 American Medical Association. All rights reserved.
Hereditary sensory and autonomic neuropathy type 1
Unit 3.
C-M-T Project in the Czech Republic
CHARCOT-MARIE-TOOTH (CMT)
Centre for Primary Immunodeficiencies, Masaryk University Brno, CR
Homozygous Defects in LMNA, Encoding Lamin A/C Nuclear-Envelope Proteins, Cause Autosomal Recessive Axonal Neuropathy in Human (Charcot-Marie-Tooth Disorder.
Different mode and types of inheritance
What does this protein make up or do? Charcot–Marie–Tooth disease
Volume 17, Issue 3, Pages (September 1996)
12.4 Mutations Kinds of Mutations Significance of Mutations.
Spinal Muscular Atrophy
Suggested algorithm for genetic testing in Charcot–Marie–Tooth disease (CMT) and related disorders in the age of disease-specific gene panels. *Motor nerve.
Genetic diagnoses in Charcot–Marie–Tooth disease (CMT) and related disorders in patients attending a specialist CMT clinic in the UK (inherited neuropathy.
Disease of the Central Nervous System By Eric Nauman
Presentation transcript:

Neurogenetics and DNA laboratory Pavel Seeman CMT team Prague

Neurogenetics „neurology of the whole family“ for clinicians : ask about and investigate the relatives !

Dept of Adult Neurology (Hereditary Neuropathies) CMT DNA laboratory in neurological departments at 2nd School of Medicine, Charles University and University Hospital Motol Prague Dept of Child Neurology (Hereditary Neuropathies, Pelizaeus Merzbacher disease, Nijmegen Breakage Syndrome) Dept of Adult Neurology (Hereditary Neuropathies) CMT Dept of Pediatric Otorhinolaryngology (Congenital Nonsyndromic Deafness – Connexin 26)

DNA testing for CMT in Czech Rep DNA testing for CMT in the Czech Republic available since 1997 – still the only lab testing for CMT Grants of Ministery of Health of Czech Republic All DNA samples and patient data from CMT patients in one lab – many advantages and great potential

Hereditary neuropathies – Charcot-Marie-Tooth diseases Most common group of genetically caused neuromuscular diseases – (1: 2 500 – 5 000) Genetically very heterogeneus group – now mutations in 23 genes can cause CMT Highly prevalent mutation is the CMT1A duplication / HNPP deletion on chromosome 17p incl. PMP22 gene Challenge for the detection methods – to small for cytogenetics, to big for molecular genetics and to close together for conventional metaphase FISH

Detection of the most common mutation in CMT in DNA laboratory Set 58°C Set 55°C now: 15 microsatellites markers located within the duplicated CMT1A region

Detection of point mutations in further genes in patients with excluded CMT1A/HNPP In patients where we have enough clinical data ! Connexin 32 gen (GJB1) – in CMTX Myelin protein zero (MPZ) – in severe demyelinating forms and in axonal form PMP22 gene – in demyelinating forms LITAF gene – in demyelinating dominant forms

Czech CMT families 1997 - 2003 548 - families tested 1271 – individuals mutation detected in total 238 families 268 individual gene tests CMT1A: 258 individuals, HNPP: 131 individuals

CMT families with enough clinical data – 408 families in 140 families out of 548 not enough clinical data were provided 408 families with sufficient clinical data

Modes of inheritance in Czech CMT patients cohort In 392 families – unrelated patients with suficient family information

Gene testing – sequencing in CMT patients without the CMT1A duplication

Connexin 32 gen, GJB1 X- linked dominant expressed in PNS as well as in CNS mutations in Cx32 are the second most common cause of CMT (after CMT1A )

Connexin 32 gene, GJB1 Investigated: 58 families without CMT1A duplication Causal mutation found in 21 families (36,2 %) Among 46 familiar cases only 45,6% Families positive for Cx32 mutation were always large many members affected by CMT One family, possibly a de-novo mutation 6 families from 13 (46%) – carry the same mutation Glu208Lys – haplotype analysis showed a founder efect – all 6 large families have a common founder

Mutation Glu208Lys in Cx32 in 6 large Czech families is due to a founder efect.

Myelin Protein Zero (MPZ) (P0) gene expressed in PNS only in myelinated Schwann cells – in central involvement 4 clinical phenotypes – due to a mutation in MPZ – – CMT1 classical (demyel.) - DSS or HMSN III- early onset severe demyel. - congenital hypomyelination (CHN)–very early onset - CMT 2 (axonal) late onset

MPZ (P0) gene investigated: 80 families without CMT1A duplication mutation found in 8 families (10 %) 4x axonal form a 4x demyelinating severe form Arg98Cys mutation 2x – in two families de-novo – hot-spot

PMP22 gene expression only in PNS – no signs of central involvement dominant mutations – heterozygotes are affected phenotype – CMT1 classical - Dejerine Sottas or congenital hypomyelination PMP22 mutations are rare worldwide

PMP 22 gene all coding exons sequenced in – 33 families/unrelated patients without CMT1A duplication mutation found in 1 patient only ( 3%) – sporadic case, congenital hypomyelination (CHN) – de-novo mutation Ser72Leu point mutations in PMP22 are rare

LITAF 1/ SIMPLE gene Lipopolysacharide-Induced Tumor necrosis Alfa Factor - Small Integral Mebrane Protein of the Lysosome/late Endosome 3 coding exons, 486 bp, 161 AA Street et al. 2003 – Neurology 60: 22-26 Mutation in LITAF/SIMPLE in CMT1C disease. 46 CMT1 families tested 2 causal mutations detected (>5 %), one is Gly113Ser in a family with very mild CMT Many polymorfisms incl. Ile92Val, Thr78Thr

Two different phenotypes caused by P0/MPZ mutation

Czech family with axonal CMT beginning with deafness

Family F.

Family F. hearing loss and deafness as the first symptom of CMT disease - at the late teens in the grandfather and in the mother - progressive hearing loss, deafness now abnormal pupillar reaction before the onset of the neuropathy fully normal physical abilities until the end of 3rd decade late onset of polyneuropathy of axonal type - slow progression at the grandfather but quite fast at the mother, 12 years old boy clinically still unaffected whorsening of electrophysiological and clinical findings correlated with higher age in the family – axonal loss and later demyelination

no pes cavus, severe footdrop pronounced hand muscles atrophies

Audiograms mother (622) son (623)

Electrophysiology Axonal polyneuropathy – very low amplitudes with preserved NCVs

Nerve and muscle biopsy in nr. 622 (mother) Normal control Normal control

290 A>T (Glu97Val) in MPZ gene

Dejerine Sottas neuropathy and MPZ mutation Deafness as late symptom in DSN patients

Family K. Mutation Arg98Cys - neighbour aminoacid to the previous family

Family K. Mother (44y.) and son (18y.) severely affected (HMSN III or DSN), no other affected members in the family early onset (3 y.) with hypotonia, delayed motor milestones, scoliosis, both affected never achieved normal independent gait distal weakness and atrophies, areflexia, rather nonprogressive course extremely decreased MNCV ( 8-10 m/s), absent SNAP hypertrofic demyelinating neuropathy (with onion- bulbs) in the sural nerve biopsy in the mother in the mother from the age of 25 y. - hearing loss, presently sensorineural hearing loss bilateral ( up to 70 dB) both affected showed abnormal pupillar reaction

Family K. son mother

Family K. mother son no foot deformities

Other, recently discovered genes in CMT (to be screened in the future in „unknown“ patients) PRX - AR demyel GDAP1 - AR - demyel., axonal and intermediar. MTMR2 - AR – focally folded myelin NEFL - AD - axonal and demyel LITAF/SIMPLE - CMT1C - AD, demyel. LMNA - AR - axonal RAB 7 - AD – axonal with ulcers NDRG1 - HMSN Lom - Bulgaria GAN - giant axonal neuropathy NTRK 1 - HSAN IV SPTLC1 - HSN I

Larger families with unknown mutation – linkage studies – new candidate genes discoveries HMN II and 12q24 locus

Linkage analysis to localize possible new „CMT genes“ AD CMT family, CMT1A, MPZ excluded

Linkage analysis to localize possible new „CMT genes“ AD-CMT family, CMT1A, MPZ, PMP22 mutations excluded electrophysiology intermediate